Basic Information
| LncRNA/CircRNA Name | RNCR3 |
| Synonyms | LINC00599 |
| Region | GRCh38_8:9900064-9905366 |
| Ensemble | ENSG00000253230 |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | glioma |
| ICD-0-3 | NA |
| Methods | qPCR, Western blot etc |
| Sample | glioma tissues , cell lines(SHG-44 and U251) |
| Expression Pattern | up-regulated |
| Function Description | Expression of RNCR3 is increased in glioma tissues and cell lines.Upregulated expression of RNCR3 is associated with progression of the disease, and poor prognosis of patients with glioma. |
| Pubmed ID | 31788110 |
| Year | 2019 |
| Title | Long Non-Coding RNA RNCR3 Promotes Glioma Progression Involving the Akt/GSK-3? Pathway |
External Links
| Links for RNCR3 | GenBank HGNC NONCODE |
| Links for glioma | OMIM COSMIC |